NanoTomer: 9/21/21
View On Demand

A Platform For An Ocean Of Opportunities

About the Event

NanoTomer is poised to launch what is arguably the broadest drug delivery platform ever developed.

NanoTomer’s patented Anti-body Drug Conjugate (ADC) targets High Endothelial Venules (HEVs) that exist only in tumor draining lymph nodes, metastatic lesions, and cancerous tumors.

This hyper precision targeting means just 1/7,000 of a traditional dose can have a greater impact on multiple cancers and immune mediated diseases like Type 1 Diabetes, Multiple Sclerosis, and more, with minimal side effects.

Join our webinar to hear the inventor of this technology, Dr. Reza Abdi and NanoTomer CEO, Jeff Bell present their pre-clinical data in preparation for an IND filing with the FDA.

Watch On-Demand Recording


All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.